What is the value of collecting detailed costing data in clinical trials?

por Dakin, Helen, Abangma, Giselle, Wordsworth, Sarah
Publicado 2011

Cost-effectiveness of ranibizumab and bevacizumab for age-related macular degeneration: 2-year findings from the IVAN randomised trial

por Dakin, Helen A, Wordsworth, Sarah, Rogers, Chris A, Abangma, Giselle, Raftery, James, Harding, Simon P, Lotery, Andrew J, Downes, Susan M, Chakravarthy, Usha, Reeves, Barnaby C
Publicado 2014